description César Milstein Overview
César Milstein (1927–2002) was an Argentine-British biochemist who spent his career at the MRC Laboratory of Molecular Biology in Cambridge, England. In 1975, together with Georges Köhler, he developed the hybridoma technique, which fuses antibody-producing B cells with immortal myeloma cells to generate unlimited quantities of identical monoclonal antibodies. This method became fundamental to diagnostics, therapeutics, and research. Milstein and Köhler shared the 1984 Nobel Prize with Niels Kaj Jerne.
insights Ranking position
César Milstein ranks #9 of 150 in the Physician ranking, behind René Laennec, ahead of Ernst Chain.
help César Milstein FAQ
What exactly did César Milstein and Georges Köhler invent?
In 1975, Milstein and Köhler developed the hybridoma technique for producing monoclonal antibodies. It fuses a short-lived antibody-producing immune cell with an immortal myeloma cell, creating a line that can repeatedly make one specific antibody.
Why are monoclonal antibodies produced by hybridomas so useful?
A hybridoma can supply large quantities of an antibody with a single, reproducible specificity. That consistency made monoclonal antibodies powerful tools for laboratory tests, cancer diagnosis, and treatments for diseases including rheumatoid arthritis.
Did César Milstein win the Nobel Prize for the hybridoma technique?
Milstein and Köhler shared the 1984 Nobel Prize in Physiology or Medicine with immunologist Niels Kaj Jerne. The award recognized discoveries concerning immune-system specificity and the principle for producing monoclonal antibodies.
Where did César Milstein conduct his antibody research?
Milstein worked at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England. Köhler joined his laboratory as a postdoctoral researcher, and their hybridoma work was published in Nature in 1975.
explore Explore More
Similar to César Milstein
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
